| Code | 1247C | ||||||||||
| MA number | 56/0434/16-S | ||||||||||
| Product Form: | tbl 20x4 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 29.09.2016 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Dexametazón Krka 4 mg_8 mg_05_2022.pdf
|
| PIL: |
PIL_Dexametazón Krka 4 mg_8 mg_05_2022.pdf
|
| Safety feature | Yes |
| Data update: | 28.09.2021 |
